Core Viewpoint - Sanofi Pharmaceutical (01530) saw a significant stock increase, rising over 7% in early trading and currently up 5.25% at HKD 30.88, with a trading volume of HKD 401 million [1] Group 1: Company Developments - Mand International has submitted an application for an independent listing on the Hong Kong Stock Exchange [1] - Mand International is recognized as a leading professional consumer pharmaceutical company in China, focusing on comprehensive and long-term solutions for skin health and weight management [1] - The company has established a leadership position in the hair health sector within the broader skin health industry [1] Group 2: Corporate Actions - Sanofi Pharmaceutical announced plans to spin off its subsidiary, Mand International, for independent listing on the Hong Kong Stock Exchange [1] - Following the spin-off, Sanofi Pharmaceutical will not retain any equity interest in Mand International, which will operate independently [1]
港股异动 | 三生制药(01530)早盘涨超7% 三生制药拟分拆子公司蔓迪国际独立上市